Cargando...
Ciclopirox activates ATR-Chk1 signaling pathway leading to Cdc25A protein degradation
Ciclopirox olamine (CPX), an off-patent anti-fungal drug, has been found to inhibit the G(1)-cyclin dependent kinases partly by increasing the phosphorylation and degradation of Cdc25A. However, little is known about the molecular target(s) of CPX responsible for Cdc25A degradation. Here, we show th...
Gardado en:
| Publicado en: | Genes Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Impact Journals LLC
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5931253/ https://ncbi.nlm.nih.gov/pubmed/29725502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/genesandcancer.166 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|